Peptide-based cancer therapy: opportunity and challenge

Area of Science:

• Oncology
• Biochemistry
• Pharmacology

Background:

• Cancer remains a leading global cause of mortality.
• Conventional cancer therapies exhibit limited specificity, leading to severe side effects.
• Peptides represent a novel therapeutic class with potential for targeted cancer cell destruction and reduced toxicity.

Purpose of the Study:

• To review the origins and mechanisms of action of anticancer peptides.
• To discuss strategies for modifying bioactive peptides to improve their anticancer efficacy.
• To highlight the potential of peptides in cancer prevention and treatment.

Main Methods:

• Literature review of scientific publications on anticancer peptides.
• Analysis of peptide sources, biological mechanisms, and therapeutic challenges.
• Exploration of peptide modification techniques for enhanced efficacy.

Main Results:

• Identification of diverse sources and mechanisms for anticancer peptides.
• Discussion of challenges in peptide-based cancer therapy.
• Overview of modification strategies to improve peptide performance.

Conclusions:

• Anticancer peptides show promise for targeted cancer therapy with reduced toxicity.
• Further research into peptide modification is crucial for optimizing therapeutic outcomes.
• Peptides offer a promising avenue for future cancer prevention and treatment strategies.